Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362

Article  CAS  PubMed  Google Scholar 

Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–1606

Article  PubMed  PubMed Central  Google Scholar 

Pinna AD, Yang T, Mazzaferro V, et al. Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma. Ann Surg. 2018;268(5):868–875

Article  PubMed  Google Scholar 

Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38(2):200–207

Article  PubMed  Google Scholar 

Zhang XF, Li J, Shen F, Lau WY. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol. 2018;33(2):347–354

Article  PubMed  Google Scholar 

Xing H, Zhang WG, Cescon M, et al. Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB (Oxf). 2020;22(5):677–689

Article  Google Scholar 

Sohn W, Paik YH, Kim JM, et al. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma. Ann Surg Oncol. 2014;21(7):2429–2435

Article  PubMed  Google Scholar 

Zhang ZH, Jiang C, Qiang ZY, et al. Role of microvascular invasion in early recurrence of hepatocellular carcinoma after liver resection: a literature review. Asian J Surg. 2024;47(5):2138–2143

Article  PubMed  Google Scholar 

Zhang K, Tao CC, Siqin TN, Wu JX, Rong WQ. Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion. J Transl Med. 2021;19(1):293

Article  CAS  PubMed  PubMed Central  Google Scholar 

FusterAnglada C, Mauro E, FerrerFàbrega J, et al. Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection. J Hepatol. 2024;S0168–8278(24):02324–02329

Google Scholar 

Chen ZH, Zhang XP, Feng JK, et al. Actual long-term survival in hepatocellular carcinoma patients with microvascular invasion: a multicenter study from China. Hepatol Int. 2021;15(3):642–650

Article  PubMed  Google Scholar 

Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–217

Article  PubMed  Google Scholar 

Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243(2):229–235

Article  PubMed  PubMed Central  Google Scholar 

Chen ZH, Zhang XP, Feng JK, et al. Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China. HPB (Oxf). 2022;24(7):1063–1073

Article  Google Scholar 

Sheng X, Ji Y, Ren GP, et al. A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC. Hepatol Int. 2020;14(6):1034–1047

Article  PubMed  Google Scholar 

Wang MD, Li C, Liang L, et al. Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma. Oncologist. 2020;25(10):e1541–e1551

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang XP, Wang K, Wei XB, et al. An eastern hepatobiliary surgery hospital microvascular invasion scoring system in predicting prognosis of patients with hepatocellular carcinoma and microvascular invasion after R0 liver resection: a large-scale, multicenter study. Oncologist. 2019;24(12):e1476–e1488

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947–955

Article  PubMed  Google Scholar 

Qu LS, Jin F, Huang XW, Shen XZ. High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2010;14(7):1111–1120

Article  PubMed  Google Scholar 

Zhang XP, Xu S, Lin ZY, et al. Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study. Int J Surg. 2023;109(4):679–688

Article  PubMed  PubMed Central  Google Scholar 

Zhang XP, Xu S, Gao YX, et al. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study. Int J Surg. 2023;109(4):785–793

Article  PubMed  PubMed Central  Google Scholar 

Yao LQ, Li C, Diao YK, et al. Grading severity of microscopic vascular invasion was independently associated with recurrence and survival following hepatectomy for solitary hepatocellular carcinoma. Hepatob Surg Nutr. 2024;13(1):16–28

Article  Google Scholar 

Xu XF, Diao YK, Zeng YY, et al. Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic area. Int J Surg. 2023;109(4):841–849

Article  PubMed  PubMed Central  Google Scholar 

Ito R, Yoshioka R, Yanagisawa N, et al. Survival analysis of conversion surgery in borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma addressing selection and immortal time bias: a retrospective single-center study. Ann Surg Oncol. 2024;31(13):8744–8755

Article  PubMed  Google Scholar 

Maeng M, Tilsted HH, Jensen LO, et al. Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial. Lancet. 2014;383(9934):2047–2056

Article  CAS  PubMed  Google Scholar 

Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol. 2005;162(10):1016–1023

Article  PubMed  Google Scholar 

Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254(1):108–113

Article  PubMed  Google Scholar 

Sun YF, Guo W, Xu Y, et al. Circulating tumor cells from different vascular sites exhibit spatial heterogeneity in epithelial and mesenchymal composition and distinct clinical significance in hepatocellularcarcinoma. Clin Cancer Res. 2018;24(3):547–559

Article  CAS  PubMed  Google Scholar 

Sun Y, Wu L, Zhong Y, et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. 2021;184(2):404-421.e416

Article  CAS  PubMed  Google Scholar 

Li Z, Tan C, Liu X, Feng Z, Li K. Early and late recurrence after hepatectomy in patients with low-level HBV-DNA hepatocellular carcinoma under anti-viral therapy. Infect Agent Cancer. 2022;17(1):56

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee IC, Lei HJ, Chau GY, et al. Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg. Am J Cancer Res. 2021;11(7):3711–3725

CAS  PubMed  PubMed Central  Google Scholar 

Wei XB, Li N, Li SS, et al. Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma. BMC Cancer. 2017;17(1):304

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Lei ZQ, Xia Y, et al. Association of preoperative anti-viral treatment with incidences of microvascular invasion and early tumor recurrence in hepatitis B virus-related hepatocellular carcinoma. JAMA Surg. 2018;153(10): e182721